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] i to investigate the mechanism underlying augmentation of Ca 2+ signalling by chronic hypoxia in type I cortical astrocytes. Application of bradykinin evoked significantly larger rises of [Ca 2+ ] i in hypoxic cells as compared with control cells. This augmentation was prevented fully by either melatonin (150 lM) or ascorbic acid (200 lM), indicating the involvement of reactive oxygen species. Given the association between hypoxia and increased production of amyloid b peptides (AbPs) of Alzheimer's disease, we performed immunofluorescence studies to show that hypoxia caused a marked and consistent increased staining for AbPs and presenilin-1 (PS-1). Western blot experiments also confirmed that hypoxia increased PS-1 protein levels. Hypoxic increases of AbP production was prevented with inhibitors of either c-or b-secretase. These inhibitors also partially prevented the augmentation of Ca 2+ signalling in astrocytes. Our results indicate that chronic hypoxia enhances agonist-evoked rises of [Ca 2+ ] i in cortical astrocytes, and that this can be prevented by antioxidants and appears to be associated with increased AbP formation. Alzheimer's disease (AD), characterized by impairments in cognition and memory, is clearly associated with the slow accumulation of amyloid b peptides (AbPs) in the central nervous system (Selkoe 2001; Small et al. 2001) . AbPs are generated via amyloidogenic processing of amyloid precursor protein (APP) by b-and c-secretases, and recent evidence suggests that c-secretase activity requires the formation of a complex between presenilin, nicastrin, APH-1 and pen-2 (Edbauer et al. 2003) . Disruption of Ca 2+ homeostasis has been strongly implicated in the neurodegeneration of AD; indeed, increased Ca 2+ -dependent protease activity occurs in association with degenerating neurones in AD brain tissue (Nixon et al. 1994) , and AbPs perturb Ca 2+ homeostasis, rendering cells susceptible to excitotoxic damage (Mattson et al. 1992) . Presenilin mutations are known to have effects on cellular Ca 2+ homeostasis (Mattson et al. 2000a) , and familial AD (FAD)-related mutations of presenilin-1 (PS-1) can alter inositol triphosphate-coupled intracellular Ca 2+ stores as well as Ca 2+ influx pathways (Leissring et al. 2000; Mattson et al. 2000a; Yoo et al. 2000) . This may contribute to neurodegeneration, since disruption of Ca 2+ homeostasis is an important mechanism underlying such loss of neurones (Chan et al. 2000; Mattson et al. 2000b; Yoo et al. 2000) . Periods of cerebral hypoxia or ischaemia can increase the incidence of AD (Tatemichi et al. 1994; Kokmen et al. 1996) , and APP expression is elevated following mild and severe brain ischaemia (Kogure and Kato 1993) . Since the non-amyloidogenic cleavage product of APP (sAPPa) is neuroprotective (Mattson 1997; Selkoe 2001) , increased expression during hypoxia could be considered a protective mechanism against ischaemia. However, increased APP levels would also provide an increased substrate for AbP formation of and, indeed, we have previously shown that AbP formation is increased following hypoxia in PC12 cells (Taylor et al. 1999; . Furthermore, we have shown in rat type I cortical astrocytes that bradykinin (BK)-induced Ca 2+ release from intracellular stores is potentiated by prolonged hypoxia. This was due to dysfunction of mitochondria and plasmalemmal Na + /Ca 2+ exchanger (NCX; Smith et al. 2003) . This observation is of particular importance, since astrocytes contribute significantly to intercellular signalling within the central nervous system . They express various receptors through which they can regulate both neuronal activity (Newman and Zahs 1997; Porter and McCarthy 1997) and local blood supply (Zonta et al. 2003) . Astrocyte activation is usually manifest as a rise of [Ca 2+ ] i (Bezzi et al. 1998; Deitmer et al. 1998; Kang et al. 1998) , and astrocytes communicate with neighbouring cells primarily via propagation of Ca 2+ signals (Giaume and Venance 1998; Araque et al. 2001) . These Ca 2+ waves can spread via transmitter release (Fam et al. 2000) or via gap junctions (Charles et al. 1992) .
Given the established link between periods of hypoxia and the development of AD, together with the increased awareness of the role for Ca 2+ signalling in astrocytes in the central nervous system, we have sought the possible involvement of reactive oxygen species (ROS) in these effects of hypoxia, and examined whether or not these effects of hypoxia are associated with amyloidogenic processing of APP.
Methods
To obtain primary cultures of astrocytes, cerebral cortices were removed from 6-to 8-day-old Wistar rats (four per preparation) and placed immediately in ice-cold buffer solution consisting of 10 mM NaH 2 PO 4 , 2.7 mM KCl, 137 mM NaCl, 14 mM glucose, 1.5 mM MgSO 4 and 3 mg/mL bovine serum albumin. Meninges were removed using fine forceps and cortices then minced with a mechanical tissue chopper (McIlwain, Missouri, USA) and dispersed into the same buffer containing 0.25 lg/mL trypsin, at 37°C for 15 min. Trypsin digestion was halted by the addition of an equal volume of buffer supplemented with 16 lg/mL soy bean trypsin inhibitor (type I-S; Sigma, Poole, Dorset, UK), 0.5 lg/mL DNase I (EC 3.1.21.1 type II from bovine pancreas; 125 kU/mL; Sigma) and 1.5 mM MgSO 4 . Tissue was pelleted by centrifugation at 1300 r.p.m. (1000 g) for 1 min. The supernatant was poured off and cell pellets resuspended in 2 mL of buffer solution containing 100 lg/mL soy bean trypsin inhibitor, 0.5 lg/mL DNase I and 1.5 mM MgSO 4 . Tissue was subsequently triturated gently three times with a fire polished Pasteur pipette. After allowing larger pieces of tissue to settle for 5 min, the cloudy cell suspension was pipetted off and centrifuged at 1300 r.p.m. for 1.5 min before resuspension into 60 mL of media. The culture medium consisted of Eagle's minimal essential medium supplemented with 10% fetal calf serum (v/v) and 1% (v/v) penicillin-streptomycin (Gibco, UK, Paisley, Scotland, UK). The cell suspension was then aliquoted into 2 · 25-cm 2 flasks and onto glass coverslips in 6-and 24-well tissue culture plates. Cells were then kept in a humidified incubator at 37°C (95% air; 5% CO 2 ). This was designated passage 1 and cells were used up to a passage of 2. Four to six hours following plating out the culture medium, cells were washed three times with fresh media to remove non-adhered cells. This resulted in a culture of primarily type I cortical astrocytes as confirmed by glial fibrillary acidic protein immunohistochemistry (data not shown). Culture medium was exchanged every 3-4 days and cells were grown in culture for up to 14 days. All recording were made from cells between days 5-12. Cells exposed to chronic hypoxia were subcultured in the same way as control cells but 24 h prior to experimentation were transferred to a humidified incubator equilibrated with 2.5% O 2 , 5% CO 2 and 2.5% N 2 [termed chronically hypoxic (CH) conditions]. Following exposure to hypoxia, cells were kept in room air for no longer than 1 h while microfluorimetric recordings took place. Corresponding control cells were maintained in a 95% air, 5% CO 2 incubator for the same period. Cells exposed to AbPs (AbP 1)40 , AbP 1)42 , AbP 25)35 and AbP 40)1 ; Sigma, UK) were treated in an identical manner to control cells but 24 h prior to experimentation amyloid b peptide was added to the culture medium to give a final concentration of 1 lM. AbPs were purchased from a number of different companies (Sigma; Biosource, Sunnyvale, CA, USA; Tocris, Bristol, UK), dissolved in sterile, distilled water (100 lM) and stored frozen in small aliquots. Aliquots were defrosted immediately before each experiment and were not subject to freeze-thaw cycles. Samples of AbPs stored in this manner were run on western blots to detect any aggregation of the peptides. No aggregation of the peptides stored in this manner was detected. Samples of the media to which AbPs had been added and which had been used to treat cells (see below) were also tested. In these samples extra bands were seen on the western blots indicating that aggregation had occurred but the vast majority of the peptide (as estimated from band density) was still in the monomeric form.
In order to measure cytosolic Ca 2+ , glass coverslips onto which cells had grown were incubated in 2 mL of control solution containing 4 lM Fura-2AM for 1 h at 21-24°C in the dark. Control solution was composed of 135 mM NaCl, 5 mM KCl, 1.2 mM MgSO 4 , 2.5 mM CaCl 2 , 5 mM HEPES and 10 mM glucose. pH was adjusted to 7.4 using NaOH and osmolarity adjusted to 300 mOsm with sucrose. Following this incubation fragments of coverslips were transferred to the stage of an inverted microscope, where cells were continuously perfused under gravity at a rate of 1-2 mL )1
. Ca 2+ measurements were made using an Openlab System [Image Processing & Vision Company Ltd (Improvision), Coventry, UK) using Fura-2 for Ca 2+ detection. Excitation was provided using a Xenon arc lamp (75 W) and excitation wavelengths (340 and 380 nm) were selected by a monochromator (Till Photonics, Planegg, Germany). A quartz fibre-optic guide transmitted light to the microscope and was reflected by a dichroic mirror (Omega Optical, Glen Spectra Ltd, Stanmore, UK) into the objective. Emission was collected through the objective and a 510 nm filter (40 nm band width). Digital images were captured at 14 bit resolution using an intensified charge-coupled device camera (Hamamatsu Photonics, Hertfordshire, UK). Fura-2 was excited alternatively at 340 and 380 nm and ratios of the resulting images were produced every 4 s. Regions of interest were used to restrict data collection to individual cells. (Bradford 1976) . Cell proteins were separated on 15%, 0.75 mm thick polyacrylamide-sodium dodecyl sulphate gels and transferred onto polyvinyl difluoride membranes (30 V overnight). Membranes were blocked with 5% non-fat milk protein/2% bovine serum albumin in PBSTween (0.05%) for 1 h and immunostained with antibodies raised against N-terminal fragment of human PS-1 for 3 h. Blots were then washed and incubated with anti-rabbit Ig conjugated to horseradish peroxidase (Amersham Pharmacia Biotech UK Ltd, Little Chalfont, Bucks, UK) and bands visualized using the enhanced chemiluminescence (ECL) detection system and hyperfilm ECL (Amersham, UK). Band intensities were measured using the Scion Image analysis software.
Results
When cells were cultured under CH conditions, application of 100 nM BK (Gimpl et al. 1992 Fig. 1 ). Such responses are exemplified in Fig. 1(a) , and quantified in terms of peak responses (Fig. 1b) and integral of transient responses (Fig. 1c) . We have previously shown that prolonged exposure of astrocytes to CH enhances BK-evoked rises of [Ca 2+ ] i through a mechanism primarily involving decreased mitochondrial Ca 2+ buffering (Smith et al. 2003) . Since mitochondria are a source of ROS, and recent studies indicate that hypoxia leads to a rise of ROS , the involvement of ROS in hypoxic remodelling of astrocytes was investigated. To do this, cells were incubated with two structurally unrelated antioxidants, melatonin or ascorbic acid, during the 24-h period of exposure to CH. Exposure of control cells to melatonin (150 lM) or ascorbic acid (200 lM) for 24 h had no effect on BK-induced [Ca 2+ ] i rises (Figs 1b  and c) . However, the potentiation of BK-evoked rises of [Ca 2+ ] i seen under CH conditions was fully prevented by either of these antioxidants (Figs 1a-c) . These antioxidants had no significant effect on basal [Ca 2+ ] i levels (in control cells, basal levels with ascorbate 0.46 ± 0.01 ratio units, and with melatonin 0.48 ± 0.02 ratio units; in CH cells basal levels with ascorbate 0.50 ± 0.02; with melatonin 0.53 ± 0.02 ratio units).
Our previous studies have shown in PC12 cells that specific effects of hypoxia are mimicked by -and, indeed, appear to require formation of -AbPs (Taylor et al. 1999; . Since many of the actions of AbPs are associated with increased levels of ROS (see, e.g. Hensley et al. 1994; Miranda et al. 2000) , we next investigated the effects of exposure of astrocytes to AbP (1)40) (1 lM, 24 h). AbP (1)40) significantly (p < 0.01) enhanced BK-induced rises of [Ca 2+ ] i as compared to control cells (Figs 2a and b) , although this enhancement was smaller than that caused by CH (Fig. 1) . Surprisingly, however, neither melatonin nor ascorbic acid prevented the AbP (1)40) -mediated enhancement of BK-induced Ca 2+ rises (Figs 2a and b) , suggesting that the effect of this peptide in rat type I cortical astrocytes is not dependent on the production of ROS. This potentiating effect was mimicked by exogenous application of AbP (25)35) , but not by the reverse sequence peptide, AbP (40)1) (both at 1 lM; Fig. 2c) . Interestingly, cells treated with AbP (1)42) , reportedly the most toxic AbP fragment (Mattson 1997; Selkoe 2001) , had no effect on BK-induced Ca 2+ rises (Fig. 2c) . All effects reported in Fig. 2 were similar when peak rises of [Ca 2+ ] i were measured instead of transient integrals (data not shown). Thus, although AbP (1)40) appeared to mimic the augmenting effects of hypoxia, the underlying mechanisms appear to differ, and are not shared by the longer peptide form, AbP (1)42) .
Despite the apparent lack of mechanistic similarities, it was clear that the effect of hypoxia to augment agonistevoked rises of [Ca 2+ ] i in astrocytes was shared by AbP (1)40) . Thus, as for PC12 cells (Taylor et al. 1999; , there was a possibility that the effects of hypoxia were somehow linked to amyloidogenic APP processing. To investigate this further, we used the monoclonal antibody 3D6 as a means to detect potential changes in AbP levels using immunohistochemistry. This antibody recognizes AbP species but, crucially, does not recognize APP or other fragments of APP (Johnson-Wood et al. 1997).
As exemplified in Fig. 3 , CH caused a marked increase in AbP immunofluorescence (Fig. 3b) as compared with control cells, where AbP immunofluorescence was barely detectable (Fig. 3a) . One mechanism that may account for increased production of AbPs under CH conditions is altered processing of APP via secretase enzymes. The protein complex that comprises c-secretase (Edbauer et al. 2003 ) is sensitive to the dipeptide-aldehyde, 2-naphthoyl-VF-CHO (c-IV), which is a potent, cell-permeable agent known to prevent formation of either Ab 1)40 and Ab 1)42 (Sinha and Lieberburg 1999) . Alternatively, amyloid production can be inhibited by blockade b-secretase activity, for example with H-KTEEI-SEVN-stat-VAEF-OH (b-secretase inhibitor, b-SI), which prevents the initial cleavage of APP and therefore subsequent Ab production . The enhanced fluorescence seen under CH conditions was attenuated when cells were incubated with either c-IV (10 lM; Fig. 3c ) or b-SI (100 nM; Fig. 3d ). These findings were consistently seen in five separate experiments. One candidate mechanism through which CH may be causing an increase in AbP production is via an increase in c-secretase activity. Figure 4a shows fluorescence images of astrocytes that were stained using a polyclonal antibody raised against the N-terminal fragment of PS-1. Clearly, as compared with control cells, this immunofluorescence was increased in CH cells. This observation was supported and quantified using western blots (Fig. 4b) : most of the PS-1 protein was detected in the cleaved, active form and since our antibody was directed at the N-terminal region of PS-1, we have termed this the N-terminal fragment. We were also able to detect low levels of intact PS-1 (Fig. 4b) , but the major observation was that both intact and cleaved forms of PS-1 were significantly increased in cells exposed to CH.
Thus far, our data indicate that CH potentiates BK-evoked rises of [Ca 2+ ] i via a mechanism involving ROS production, and also that CH has pro-amyloidogenic effects, increasing both AbP and PS-1 levels in astrocytes. Since presenilins, particularly PS-1, are also known to have effects on cellular Ca responses to BK of control cells. However, responses observed in CH cells were significantly attenuated (p < 0.01) using either blocker (Figs 5a and b) . These data suggest that at least part of the enhancement of BK-evoked rises of [Ca 2+ ] i caused by CH is attributable to amyloidogenic APP processing.
Discussion
The present study was conducted to investigate the mechanism(s) underlying the ability of CH to potentiate agonistevoked rises of [Ca 2+ ] i observed in the absence of Ca 2+ influx (i.e. liberation of Ca 2+ from intracellular stores). We have previously shown that this action of CH arises not by an increase in the size of the ER Ca 2+ store, but by a reduced buffering capacity of the cell, with the most functionally important site of reduced buffering capacity being the mitochondria (Smith et al. 2003) . Mitochondria are less capable of buffering rises of cytoplasmic [Ca 2+ ] following CH because they become hyperpolarized and so already contain excess Ca 2+ levels (Smith et al. 2003) . Importantly, such hyperpolarization has been shown to lead to increased production of ROS (Lee et al. 2002) , and ROS have been implicated in the inhibition of the plasmalemmal NCX (Nicholls and Ward 2000) , the second site of reduced Ca 2+ buffering observed in CH astrocytes (Smith et al. 2003) . The work in this present study was in part therefore conducted in order to determine the role for ROS in the CH-mediated disturbance of Ca 2+ homeostasis. In addition, given the close association of CH-mediated alterations in cell function and those of AbPs, together with the observation that CH can increase AbP levels (Taylor et al. 1999; Peers 2001, 2002; , led us to investigate a possible role for pro-amyloidogenic APP processing in these cells. Our initial observation was that the effects of CH on BK-induced Ca 2+ rises were fully reversed by the antioxidants melatonin or ascorbate (Fig. 1) , implying that the effects of CH are mediated by ROS. This observation is in accordance with the recent report by Duchen and colleagues that mitochondrially generated ROS cause mitochondrial Ca 2+ loading from ER stores in astrocytes (Jacobson and Duchen 2002) . This Ca 2+ loading into the mitochondria would in turn render the mitochondria less able to buffer cytosolic Ca 2+ rises. The nature of the mechanism underlying NCX inhibition is not presently clear, but it has been suggested that mitochondrial Ca 2+ accumulation specifically inhibits the NCX in COS cells transfected with a bovine NCX (Opuni and Reeves 2000) , yet no mechanism for this was provided. Whether or not ROS derived from mitochondria interact directly with NCX to alter its function, or other mitochondrial factor(s) are responsible for NCX inhibition remains to be determined.
Several reports have found that AbP deposition is increased following a period of cerebral ischaemia (Yokota et al. 1996; Niwa et al. 2002) . It has also been shown in PC12 cells that the actions of hypoxia on Ca 2+ influx can be mimicked by the exogenous application of AbP, and also that the effects of this peptide were dependent on its ability to produce ROS . Application of AbP (1)40) for 24 h significantly enhanced BK-induced Ca 2+ rises in astrocytes, yet this rise was significantly smaller than that seen under CH conditions (Figs 2a and b) . This effect was mimicked by AbP (25)35) but not by the reverse sequence AbP fragment AbP (40)1) . Surprisingly, AbP (1)42) , generally considered to be the most toxic AbP fragment (Jarrett et al. 1993) , also failed to influence Ca 2+ homeostasis. It is important to note that we have previously demonstrated in PC12 cells that this peptide can indeed mimic the actions of AbP (1)40) (e.g. Green and Peers 2001) , so the lack of effect shown here cannot be attributable to solubility status of this peptide.
One mechanism through which AbP is supposed to mediate its effects is via the production of ROS (Hensley et al. 1994) . However, the antioxidants melatonin and ascorbic acid failed to influence AbP (1)40) -enhanced, BK-induced [Ca 2+ ] i rises in astrocytes (Fig. 2) . Defects in energy metabolism are a consistent feature of the AD-affected brain and AbPs have been shown to interact with the respiratory chain, thereby reducing cellular ATP levels (Casley et al. 2002) . Given the importance of mitochondria in buffering cytosolic Ca 2+ rises in astrocytes (Boitier et al. 1999; Smith et al. 2003) , any interaction of the AbP with mitochondrial function might be expected to influence Ca 2+ homeostasis. As has been reported, AbP itself can interact with NCX directly and interfere with plasma membrane Ca 2+ transport. This has been shown not to be a ROS-mediated effect, as various antioxidants have failed to reverse the NCX inhibition (Wu et al. 1997) . Thus, NCX inhibition by AbP itself seems a likely explanation for the small, yet significant enhancement of BK-induced Ca 2+ rises seen in AbP (1)40) treated cells.
Recent evidence strongly suggests that AbP (1)40) and AbP (1)42) are cleaved from amyloid precursor protein (APP) by the sequential actions of the b-and c-secretase (Selkoe and Podlisny 2002) , with the c-secretase being a heteromultimeric protein including PS-1 (Edbauer et al. 2003) . Under hypoxic conditions, the degradation of the hypoxia inducible factor subunit, HIF-1a, is suppressed and the transcription of mRNAs encoding hypoxia responsive genes can occur (Safran and Kaelin 2003) . Recently, HIF binding regions in the PS-1 gene promoter regions have been described (Bazan and Lukiw 2002) potentially representing a site at which O 2 levels can regulate PS-1 activity. Indeed following a period of chronic hypoxia, not only are PS-1 levels elevated (Fig. 4) , but also the product of c-secretase/PS-1 activity, AbPs (Fig. 3) . Further evidence of increased PS-1 expression is provided by the ability of the b-and c-secretase inhibitors to prevent hypoxic increases in AbP levels, as shown immunocytochemically (Figs 3c and d) . Current lack of a viable ELISA assay for rat AbPs, coupled with the fact that even under hypoxic conditions AbP levels are too low to detect in western blots in these cells, has meant we currently have to rely on immunocytochemistry to detect AbPs. However, the monoclonal antibody used (3D6) is known not to recognize APP or derivatives other than AbPs (Johnson-Wood et al. 1997 ) and so results obtained may be considered reliable.
Recently, LaFerla and colleagues described a physiological signalling role for the c-secretase-derived intracellular fragment of APP (Leissring et al. 2002) . Cleavage of APP by c-secretase/PS-1 liberates a fragment, the APP intracellular cleaved domain (AICD), which interacts with the nuclear adaptor protein, Fe65. Leissring et al. (2002) showed that blockade of AICD production impaired phosphoinositidemediated Ca 2+ signalling. In rat type I cortical astrocytes application of either the b-or c-secretase inhibitors for a period of 24 h had no effect on control BK-induced [Ca 2+ ] i rises (Fig. 5) , suggesting that AICD plays no role in controlling Ca 2+ homeostasis under normoxic conditions. However, PS-1 expression is increased (Fig. 4) , potentially increasing the production of AICD. When cells were cultured under a hypoxic environment for 24 h in the presence of either the b-or c-secretase inhibitor, BK-induced Ca 2+ rises were partially, but significantly, reduced as compared with [Ca 2+ ] i rises seen in CH cells (Fig. 5) . Thus, part of the enhanced Ca 2+ response seen upon application of BK may be via an amyloidogenic pathway.
Under normoxic conditions, proline residues in HIF-1a are hydroxylated. These hydroxylated prolines acts as recognition sites for the von Hippel-Lindau tumour-suppressor protein (pVHL), permitting ubiquitin-targeted degradation (Safran and Kaelin 2003) . Under hypoxic conditions, proline hydroxylation does not occur, preventing pVHL binding and subsequent degradation (Hofer et al. 2002) . However, recently, Chandel and colleagues have provided an alternative explanation for the stabilization of HIF-1a under hypoxic conditions that involves ROS (Schroedl et al. 2002) . In this study, cells lacking mitochondrial DNA (so called q 0 cells) failed to generate ROS or stabilize HIF-1a in response to hypoxia. Therefore it is possible that under hypoxic Pro-amyloidogenic effects of hypoxia 875 conditions, the increased production of ROS (which in itself causes Ca 2+ dyshomeostasis), stabilizes HIF-1a and this in turn interacts with the HIF binding domain of PS-1, increasing the production of the AICD complex with further resultant disturbances in Ca 2+ homeostasis (as illustrated in Fig. 6 ). In support of this hypothesis, when cells were incubated with the secretase inhibitors, there was only a partial reduction in enhancement of the BK-induced Ca 2+ rise seen in CH levels (Fig. 5 ) presumably because these inhibitors have no effect on ROS-mediated disturbances of Ca 2+ homeostasis. However, when cells were incubated with antioxidants, ROS are scavenged and therefore no ROSmediated Ca 2+ dyshomeostasis occurs, HIF-1a is not stabilized, PS-1 expression is not induced, thus AICD is not produced to mediate Ca 2+ dyshomeostasis. Thus the model of O 2 sensing involving ROS production by mitochondria provided by Chandel and colleagues (Schroedl et al. 2002) , provides a potential pathway in which O 2 sensing interacts with amyloidogenesis.
